Interestingly, immunofluorescence (Fig. 1C) and western blot analysis (Fig. 1D) on murine tumor mass showed that PD-L1 expression was decreased in TME of mice treated with the β3-AR antagonist compared to vehicle condition. This evidence concerns the gene ADRB3 and neoplasm.